Bi-directional communication between neurons and astrocytes modulates spinal motor circuits by Broadhead, Matthew James & Miles, Gareth Brian
ORIGINAL RESEARCH
published: 27 February 2020
doi: 10.3389/fncel.2020.00030
Edited by:
Jonathan Mapelli,
University of Modena and Reggio
Emilia, Italy
Reviewed by:
Rita Bardoni,
University of Modena and Reggio
Emilia, Italy
Patrick John Whelan,
University of Calgary, Canada
*Correspondence:
Gareth B. Miles
gbm4@st-andrews.ac.uk
Received: 01 November 2019
Accepted: 03 February 2020
Published: 27 February 2020
Citation:
Broadhead MJ and Miles GB
(2020) Bi-Directional Communication
Between Neurons and Astrocytes
Modulates Spinal Motor Circuits.
Front. Cell. Neurosci. 14:30.
doi: 10.3389/fncel.2020.00030
Bi-Directional Communication
Between Neurons and Astrocytes
Modulates Spinal Motor Circuits
Matthew J. Broadhead and Gareth B. Miles*
School of Psychology and Neuroscience, University of St Andrews, St Andrews, United Kingdom
Evidence suggests that astrocytes are not merely supportive cells in the nervous system
but may actively participate in the control of neural circuits underlying cognition and
behavior. In this study, we examined the role of astrocytes within the motor circuitry
of the mammalian spinal cord. Pharmacogenetic manipulation of astrocytic activity
in isolated spinal cord preparations obtained from neonatal mice revealed astrocyte-
derived, adenosinergic modulation of the frequency of rhythmic output generated by the
locomotor central pattern generator (CPG) network. Live Ca2+ imaging demonstrated
increased activity in astrocytes during locomotor-related output and in response to
the direct stimulation of spinal neurons. Finally, astrocytes were found to respond
to neuronally-derived glutamate in a metabotropic glutamate receptor 5 (mGluR5)
dependent manner, which in turn drives astrocytic modulation of the locomotor network.
Our work identifies bi-directional signaling mechanisms between neurons and astrocytes
underlying modulatory feedback control of motor circuits, which may act to constrain
network output within optimal ranges for movement.
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LAY SUMMARY
We have investigated how astrocytes, a type of supportive cell within the nervous system, may
be directly involved in the control of movements, such as walking (locomotion). We found that
astrocytes are active participants in the neural circuits of the mammalian spinal cord that control
locomotion. The function of astrocytes within these networks appears to relate to the modulation
of locomotor speed. We also identify the chemical signaling pathways involved in a modulatory
feedback loop between astrocytes and neurons. Our findings suggest that this bi-directional
communication between astrocytes and neurons may act to constrain spinal motor circuits within
operational ranges for desired movements.
INTRODUCTION
Astrocytes, one of the predominant forms of glial cells in the nervous system, are a diverse
and multifunctional group of cells with the capacity to integrate numerous neuronal-derived
signals and modulate neuronal activity at a network level (Verkhratsky and Butt, 2013).
There is growing evidence that astrocytes play a role in a wide range of basic central nervous
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system (CNS) functions (Gibbs et al., 2008; Robertson, 2018).
Within motor systems, astrocytes are implicated in the control
of rhythmic behaviors, such as respiration (Gourine et al., 2010;
Huxtable et al., 2010; Sheikhbahaei et al., 2018), mastication
(Morquette et al., 2015), feeding (Yang et al., 2015; Sweeney
et al., 2016) and locomotion (Acton and Miles, 2015, 2017; Witts
et al., 2015; Acton et al., 2018). These rhythmic motor behaviors
are generated by a dedicated central pattern generator (CPG)
networks. For example, the lumbar spinal cord contains a CPG
network that consists of interneurons, which generate rhythmic
activity, and motor neurons, which convey the network’s output
to coordinate alternating left-right and flexor-extensor muscle
activation as required for the generation of locomotor behavior
(Grillner, 2003, 2006; Selverston, 2005; Kiehn, 2016). CPGs
underlying behaviors such as locomotion, respiration, chewing
and gut motility, require various modulatory mechanisms to
fine-tune the speed, pattern and power of behavior in accordance
with the requirements of the animal at any given time (Harris-
Warrick, 2011; Miles and Sillar, 2011). Although neurons have
traditionally been considered the primary, if not sole, source of
such modulation, a growing body of evidence supports important
roles for astrocytes in the modulation of CPG networks (Gourine
et al., 2010; Acton and Miles, 2015; Morquette et al., 2015; Yang
et al., 2015).
Previous research suggests that pharmacological activation or
ablation of spinal cord astrocytes alters the synaptic activity of
interneurons and modulates the frequency of locomotor output
(Witts et al., 2012, 2015; Carlsen and Perrier, 2014; Acton and
Miles, 2015; Acton et al., 2018). These effects are thought to
be dependent on the astrocytic release of ATP with subsequent
conversion to adenosine, which acts via neuronal A1 adenosine
receptors. Although these findings support that astrocytes are
active participants within locomotor circuitry, further analyses
utilizing additional methods for activating and, importantly,
inhibiting endogenous astrocytic activity are required to provide
a greater understanding of their functional roles. Furthermore,
if spinal cord astrocytes are indeed active participants in the
locomotor CPG, then it is likely their role is driven by neuronally-
derived signals, which remain to be identified. Given growing
evidence that astrocytes play a role in a host of neurological
and neurodegenerative diseases, including chronic pain (Ji et al.,
2006; Gao and Ji, 2010), spinal cord injury (Okada et al.,
2006) and Amyotrophic Lateral Sclerosis (ALS; Phatnani et al.,
2013; Pehar et al., 2018), identifying the physiological roles of
astrocytes within spinal circuits, and the signaling mechanisms
involved, could pave the way for the development of novel
therapeutic strategies.
In this study, we aimed to further our investigation into
whether spinal cord astrocytes are active participants within
mammalian locomotor circuits and identify the signaling
mechanisms between spinal neurons and astrocytes. To
address these aims, we have used transgenic mouse lines
to both visualize and manipulate astrocytic activity in the
isolated mammalian spinal cord in vitro. We reveal neuron-
astrocyte and astrocyte-neuron signaling mechanisms that
underlie modulatory, inhibitory feedback control of motor
circuit output.
MATERIALS AND METHODS
Animals
All procedures performed on animals were conducted in
accordance with the UK Animals (Scientific Procedures) Act
1986 and were approved by the University of St Andrews
Animal Welfare and Ethics Committee. Mice were euthanized
via cervical dislocation and decapitation. All lines of mice were
obtained from Jackson Laboratories and are listed in Table 1.
To induce expression of genes in astrocytes, heterozygous
GFAP::Cre transgenic mice were injected with 100 µg/g mouse
weight of Tamoxifen (Sigma) starting from neonatal day 5 (P5)
with subsequent injections every 24 h until sacrificed for the
experiment. Experiments requiring ventral root recordings of
fictive locomotion in whole isolated spinal cords and hemisected
spinal cords of transgenic mice were performed at P6–8. Ca2+
imaging experiments were performed on neonates at P6–10.
Where transgenic mice were not required for fictive locomotor
experiments (with the exception of the non-transgenic controls
for DREADD experiments), mice aged P1–5 were used as
obtaining fictive locomotion is more reliable in younger mice.
Tissue Preparation
For ventral root recordings from whole isolated spinal cords
or hemisected spinal cords, animals were sacrificed by cervical
dislocation, decapitated and eviscerated before being transferred
to a dissection chamber containing artificial cerebrospinal fluid
(aCSF, equilibrated with 95% O2, 5% CO2, ∼4◦C). Spinal
cords were isolated between the midthoracic and upper sacral
segments, and the dorsal roots trimmed, leaving ventral roots
intact. For hemisected spinal cords, the pia was carefully removed
and the two halves cleaved gradually with a dissecting pin. For
preparing acute spinal cord slices, neonatal mice were sacrificed
as described above, and the spinal cord dissected in aCSF. Slices
were made at 300 µm thickness from the lumbar segments
using a vibratome (VT1200, Leica) and transferred to recovery
aCSF maintained at ∼34◦C (equilibrated with 95% O2, and 5%
CO2) for 30–60 min. Slices were subsequently transferred to
recording aCSF.
Drugs and Solutions
Recording aCSF contained the following (in mM): 127 NaCl,
3 KCl, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl, 26 NaHCO3, and
10 glucose. The dissecting aCSF contained the following (in mM):
25 NaCl, 188 sucrose, 1.9 KCl, 1.2 NaH2PO4, 10 MgSO4, 1 CaCl,
26 NaHCO3, 25 glucose, and 1.5 kynurenic acid. The recovery
aCSF contained the following (in mM): 119 NaCl, 1.9 KCl,
1.2 NaH2PO4, 10 MgSO4, 1 CaCl, 26 NaHCO3, 20 glucose,
and 1.5 kynurenic acid. Intracellular solution used for single-cell
recordings contained the following (in mM): 140 KMeSO4,
10 NaCl, 1 CaCl, 10 HEPES, 1 EGTA, 3 Mg-ATP, and 0.4 GTP-
Na2 (pH 7.2–7.3, adjusted with KOH).
The following drugs were purchased from Sigma:
Glutamate, γ-aminobutyric acid (GABA), N-methyl-D-aspartate
(NMDA) and Dopamine (DA). The following drugs were
purchased from Tocris: 8-Cyclopentyl-1,3-dipropylxanthine
(DPCPX), 2-Methyl-6-(phenylethynyl)pyridine hydrochloride
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TABLE 1 | Details of the transgenic mouse lines used for the study.
Jackson laboratories stock number Full name Abbreviated name Purpose
012849 hGFAP::CRE/ERT2 GFAP::Cre Tamoxifen inducible cre expression in astrocytes
024106 Ai96(RCL-GCaMP6s) GCAMP6s Fluorescent Ca2+ indication
026220 R26-LSL-hM3Dq-DREADD hM3Dq Excitatory DREADD receptor
026219 R26-LSL-hM4Di-DREADD hM4Di Inhibitory DREADD receptor
007905 Gt(ROSA)26Sortm9(CAG-tdTomato)Hze TdTomato Fluorescence reporter line
(MPEP), 5-hydroxytryptamine (5-HT) and (RS)-2-Chloro-
5-hydroxyphenylglycine (CHPG). Tetrodotoxin (TTX) and
CNO were purchased from HelloBio. With the exception of
Glutamate, CHPG, MPEP and DPCPX, all drugs were made up
in deionized H2O. Glutamate and CHPG were made up in 1 M
NaOH, while MPEP and DPCPX were made up in dimethyl
sulfoxide (DMSO). CNO and DPCPX were prepared fresh on
a weekly basis. Drug concentrations were chosen based on
previous publications (Bowman and Kimelberg, 1984; Queiroz
et al., 1999; Parri et al., 2010; Iwagaki and Miles, 2011; Takeuchi
et al., 2014; Acton and Miles, 2015; Mariotti et al., 2016; Jennings
et al., 2017).
Ca2+ Imaging
Ca2+ imaging of spinal cord slices was performed in aCSF
(equilibrated with 95% O2, 5% CO2) warmed to ∼34◦C with
an inline heater (Warner Instruments). Imaging of hemisected
spinal cords was performed at 20–24◦C in order to ensure robust
fictive locomotor output. Images were captured as described
in Acton et al. (2018). Briefly, images were acquired using a
Zyla 4.2 scientific CMOS camera (Andor, Oxford Instruments)
using a 40× water immersion objective lens (0.9 numerical
aperture), controlled using Micro-Manager 2 software. Data
were acquired with a rolling shutter at 1 fps with a 200 ms
exposure time. Illumination was provided by a 470-nm CoolLED
system. Analysis of Ca2+ imaging was performed with FIJI
software. Data were first converted to eight bit and processed
with background subtraction, 3D smoothing and histogram-
based bleach correction. If required, manual drift correction
was performed. Active cells were selected and delineated from
the images, guided by a maximum intensity projected image to
highlight high-intensity structures. Intensity measurements were
normalized as ∆F/F0, calculated as:
100 × (fluorescence value − baseline fluorescence ÷ baseline
fluorescence).
Baseline fluorescence was calculated as the mean intensity
from 30 frames during a control period of recording. Ca2+
transients from astrocytes in hemisected spinal cords were
detected in a semi-automated manner using Hill-Valley analysis
through Dataview software (courtesy of Dr. W. J. Heitler,
University of St Andrews). Events were detected using a slope
height filter of 10% of the valley-to-peak height. Due to variation
in Ca2+ event intensity and duration, false-positive events were
excluded manually and some false negative events were selected
manually. In hemisect experiments where events were analyzed
with Dataview, Ca2+ event intensity was calculated from the
normalized intensity, averaged across all the events within a
time window for a cell and across cells of each experiment. The
maximum intensity of cells is taken as the maximum normalized
intensity for a cell within a time frame. Ca2+ images are displayed
in figures as maximum projections from across 120 frames
following initial processing steps.
Whole-Cell Patch-Clamp
Whole-cell patch-clamp recordings were performed from ventral
horn interneurons using glass microelectrodes (2.5–5 MΩ) filled
with intracellular solution. Signals were amplified and filtered
(4 kHz low-pass Bessel filter) with a Multi-Clamp 700B amplifier
(Molecular Devices) and acquired at 10 kHz using a Digidata
1440A A/D board and pClamp software (Molecular Devices).
Gigaseals (∼2 GΩ) were obtained before the establishment of
whole-cell mode and neurons with resting membrane potentials
between −40 mV and −70 mV were used for experiments.
All recordings were performed in current-clamp mode. Cells
were given a 10 s pulse of 200 pA to induce trains of action
potentials (eliciting ∼100 action potentials). All experiments
were conducted at∼34◦C.
Ventral Root Recording
For whole spinal cord preparations in which locomotor-related
activity was induced pharmacologically, glass suction electrodes
were attached to the upper lumbar segment roots (L1–3) on
both the left and right side of the isolated spinal cords to
assess left-right alternation and flexor-related activity. Fictive
locomotion was induced with 5-HT (10 µM), NMDA (5
µM) and DA (50 µM). Preparations displaying stable fictive
locomotion for ∼20 min during control periods were used for
full experiments with the addition of additional drugs. Data
were amplified and filtered (band-pass filter 10–5,000 Hz, A-M
Systems Model 1700) and acquired at a sampling frequency
of 6 kHz with a Digidata 1440A analog-digital converter and
Axoscope software (Molecular Devices, Sunnyvale, CA, USA).
For hemisected spinal cord experiments with simultaneous
Ca2+ imaging, only one root was attached (L1–L3). Data were
amplified and filtered (30–3,000 Hz; Qjin Design) and then
acquired at a sampling frequency of 6 kHz using a Digidata
1440A A/D board and AxoScope software.
Immunohistochemistry and Fluorescence
Microscopy
Spinal cords from wild type, non-transgenic C57Bl/6J mice (P6)
were harvested in ice-cold recording aCSF and subsequently
fixed in paraformaldehyde (4%) for 4 h at 4◦C. Cords were then
sunk in a 33% sucrose solution overnight and cryo-embedded for
cryosectioning at 20 µm thickness. Frozen sections were washed
in 0.1 M phosphate-buffered saline (PBS) and then blocked and
permeabilized in 5% Bovine serum albumin (BSA) and 0.2%
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Triton X100 for 90 min at room temperature. Sections were
incubated for 48 h at 4◦C with a primary antibody solution
of 2.5% BSA and 0.1% Triton X100 with rabbit polyclonal
anti-mGluR5 (Abcam) and mouse monoclonal anti-glutamine
synthetase (Abcam), both at 1:200 dilution. Sections were
then washed five times with PBS before a secondary antibody
incubation in 0.1% Triton X100 for 60 min at room temperature.
Following another five washes in PBS, sections were washed once
briefly in DI-H2O and incubated in DAPI (diluted 1:5,000 in
deionized-H2O) for 5 min before mounting in vectashield. Fixed,
stained samples were imaged at 63× with a Zeiss Axio Imager
M2 microscope equipped with an Apotome.2. Illumination was
provided by an HXP120 lamp, and images acquired using
an MRm digital camera. Three-channel images of glutamine
synthetase, mGluR5 and DAPI were captured with exposure
times of 500, 100 and 30 ms, respectively. Z-stacks were acquired
with all channels per slice and an optimal z-step of 0.28 µm.
Images were processed and visualized in FIJI (ImageJ).
Data Handling and Statistics
All data were stored using a 20 TB NAS drive, with hot-swappable
hard drives and a back-up NAS drive (QNAP Turbo). Data files
and graphs were handled and produced in Excel (Microsoft).
Statistics were performed with SPSS v24 and SPSS v25 (IBM).
Shapiro Wilks tests were performed to assess normality.
Fictive locomotor experiments were analyzed using repeated-
measures ANOVAs with a post hoc Bonferroni test for pairwise
comparisons. Where appropriate, sphericity was assessed with
Mauchly’s test and Greenhouse-Giesser corrections were applied.
For Ca2+ imaging data where two or more groups were
compared, one-way ANOVAs with post hoc Tukey’s test for
pairwise comparisons were performed. For Ca2+ imaging with
two groups, two-sample T-tests were performed. Significance
is given as ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 and not
significant (ns). Ca2+ traces from astrocytes are displayed with
a mean smoothing over five frames. Bar charts display mean with
standard error bars. Samples sizes (n) are stated in the results
where appropriate.
RESULTS
Spinal Cord Astrocytes Respond to
Neuronal Activity
We first asked whether spinal astrocytes were active during
fictive locomotion. Hemisected spinal cords were prepared
from neonatal (P6–8) GFAP::Cre;GCAMP6s mice to enable the
visualization of gray matter astrocytes, broadly in laminae VII,
VIII and X, whilst simultaneously recording fictive locomotor
output via lumbar segment roots (L1–3; depicted in the
schematic of Figure 1A).
Across all experiments (108 astrocytes from n = 6 hemisected
spinal cords), the average density of astrocytes displaying Ca2+
transients, as indicated by changes in fluorescence, was 400 cells
per mm2 (ranging from 80 to 690 cells per mm2 between
experiments). Astrocytes showed little to no activity during
the ‘‘control’’ phase of recording, with an average frequency
of 0.1 transients per minute (Figure 1B). After 3–4 min of
control recording, DA (50 µM), 5-HT (10 µM) and NMDA
(5 µM) were perfused to evoke fictive locomotion. Within
1–2 min of drug perfusion, a tonic increase in motor neuron
activity was observed, as evidenced by an increase in the baseline
of ventral root recordings, which lasted approximately 5 min.
This tonic activity was followed by rhythmic locomotor-related
bursts which first appeared 6–10 min after the perfusion of
the locomotor drugs. Astrocytic Ca2+ transients showed no
significant change in their duration (Figure 1C; F(3) = 0.63;
p = 0.602) or intensity (Figure 1D; F(3) = 2.1; p = 0.133)
during these different phases of ventral root output. There was
also no significant change in the frequency of astrocytic Ca2+
transients immediately following the addition of the locomotor
drugs nor during the induction phase when tonic ventral root
activity was recorded. However, the frequency of astrocytic Ca2+
transients significantly increased above baseline levels during the
period when rhythmic, locomotor-related bursting was present
(Figure 1E; F(3) = 3.6; p = 0.032). There was no specific coupling
between individual astrocytic Ca2+ transients and single fictive
locomotor bursts, perhaps due to the fact that the locomotor
bursts recorded from ventral roots averaged 4 s in duration,
while astrocytic Ca2+ transients averaged 25 s in duration.
Nevertheless, there was a significant increase in the occurrence
of astrocytic Ca2+ transients when fictive locomotor network
activity was established.
We next confirmed that elevations in astrocytic activity were
due to locomotor network activity, rather than a direct astrocytic
response to the drugs used to induce locomotor-related output.
We performed a series of hemisected spinal cord experiments
in the presence of (TTX, 0.5 µM) to block neuronal activity
(Figure 1F). As expected, no motor output was evoked when DA,
5-HT, and NMDA were applied in the presence of TTX. Analysis
of astrocytic activity in these experiments (89 astrocytes from
n = 6 hemisected spinal cords), revealed no significant change in
the duration (F(3) = 1.2; p = 0.326), intensity (F(3) = 1.3; p = 0.291)
or the frequency (Figure 1F; F(3) = 0.78; p = 0.516) of Ca2+
transients after the addition of the locomotion-inducing drugs.
These results suggest that spinal cord astrocytes are responsive to
neuronal activity in the spinal cord, rather than any direct actions
of the drugs used to induce locomotor-related activity.
We next asked whether spinal cord astrocytes could respond
directly to interneurons within the spinal cord. To test this, we
used whole-cell patch-clamp electrophysiology to evoke trains
of action potentials in individual interneurons in spinal cord
slices from GFAP::Cre;GCAMP6s mice (Figure 1G). A total of
nine neurons were patched and stimulated. In eight out the nine
experiments, we observed Ca2+ responses in astrocyte somas
following neural stimulation (measurements from 53 astrocytes
from n = 8 slice experiments; Figures 1H,I). The maximum
intensity (∆F/F0), averaged from responsive astrocytes within
individual experiments, rose by 19.4± 15.3% following neuronal
stimulation (Figure 1J; F(2) = 4.4; p = 0.024).
Astrocytic mGluR5 Receptors Mediate
Neuron-to-Astrocyte Signaling
Next, we sought to address how neurons were signaling
to astrocytes in the spinal cord. Spinal cord slices were
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FIGURE 1 | Neuronal activity evokes Ca2+ responses in spinal astrocytes. (A) Schematic of hemisected spinal cord preparations in which simultaneous ventral root
recording and Ca2+ imaging of astrocytic activity were performed. (B) Example data from one experiment showing ventral root activity from baseline to the induction
of fictive locomotion and Ca2+ imaging traces from four astrocytes (denoted in panel A). Red lines above traces indicate the Ca2+ events detected for analysis. (C)
Bar chart showing the duration of astrocytic Ca2+ transients during different phases of the experiment. (D) Bar chart showing the intensity of astrocytic Ca2+
transients during different phases of the experiment. (E) Bar chart showing the frequency of astrocytic Ca2+ transients during different phases of the experiment. (F)
Bar chart showing the frequency of astrocytic Ca2+ transients during different phases of the experiment when the hemisected cord was perfused with tetrodotoxin
(TTX). (G) Schematic of a spinal cord slice with a simultaneous whole-cell patch-clamp recording from a ventral horn interneuron and Ca2+ imaging of astrocytic
activity. (H) Example data from one experiment showing the activation of a spinal cord interneuron (IN), and the Ca2+ transients from three astrocytes (denoted in
panel G). (I) Averaged Ca2+ imaging trace from 52 astrocytes from eight separate experiments in response to neuronal stimulation. (J) Bar chart showing the
maximum intensity of Ca2+ transients in astrocytes before and after neuronal stimulation. ∗p < 0.05.
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prepared from neonatal (P6–10) GFAP::Cre;GCAMP6s mice and
astrocytic activity was visualized while receptor agonists were
locally applied to the recording chamber to evoke responses
from astrocytes (Figure 2A). Experiments were conducted in
the presence of TTX (1 µM) to block neuronal activity. Positive
responses from astrocytes within an experiment were defined
as an increase in normalized fluorescence intensity (∆F/F0)
of at least 5% occurring within 2 min of agonist application
(Figures 2A,B).
Glutamate and the metabotropic glutamate receptor 5
(mGluR5) agonist, CHPG, both elicited strong Ca2+ responses
from large numbers of astrocytes, significantly more so than the
vehicle control (aCSF; CHPG: p = 0.003; Glutamate: p = 0.0002),
5-HT (CHPG: p = 0.007; Glutamate: p = 0.001) and NMDA
(CHPG: p = 0.04; Glutamate: p = 0.029). GABA and DA also
evoked moderate responses from astrocytes, though the number
of astrocytes that responded was far less than the number
that responded to Glutamatergic signaling, and not significantly
greater than control. Based on cell density measurements
from a TdTomato fluorescence reporter (n = 12 slices
from two individual GFAP::Cre;TdTomato mice aged P8–9;
Supplementary Figure S1), we estimate that approximately
70–100% of astrocytes are activated by Glutamate and CHPG.
From these results, we conclude that glutamatergic signaling
via metabotropic receptors is the most probable mechanism by
which spinal neurons communicate with astrocytes.
Next, we sought to confirm whether spinal astrocytes express
the mGluR5 receptor. Immunolabeling experiments revealed
widespread expression of the mGluR5 receptor in the neonatal
spinal cord (Figures 2C,D). Co-labeling with the astrocytic
marker, Glutamine Synthetase, confirmed that mGluR5 is
expressed on the soma, primary branches and smaller branchlets
of astrocytes (Figures 2C,D, arrows).
Finally, we examined whether the mGluR5 antagonist, MPEP,
could reduce neuron-to-astrocyte communication. Having
previously shown that astrocytes do not respond to NMDA
directly in the presence of TTX, we applied NMDA to spinal
cord slices for 5 min to evoke neuronal activity while visualizing
astrocyte Ca2+ activity (221 astrocytes from n = 7 slice
experiments). Any astrocytic responses were, therefore, the
indirect result of enhanced neuronal activity induced by NMDA
(Figure 2E). In a second condition (124 astrocytes from
n = 6 slice experiments), slices were incubated in MPEP (50 µM)
15–20 min prior to, and during, NMDA application (Figure 2F).
Analysis of Ca2+ imaging data revealed that MPEP reduced
both the degree of astrocytic activation, as determined by the
maximum intensity (Figure 2G; t = 2.4; p = 0.038), and the
number of activated astrocytes (Figure 2H; t = 3.2; p = 0.008).
Pharmacogenetic Manipulation of
Astrocytic Activity Modulates Fictive
Locomotion
Finally, we wanted to determine whether manipulating neuronal-
astrocyte interactions would modulate the locomotor CPG
output. In previous studies, we have used pharmacological
methods to excite spinal astrocytes (Acton and Miles, 2015;
Acton et al., 2018). Here we decided to employ pharmacogenetics
to more specifically excite and inhibit astrocytes, an approach
that has been used by others to manipulate astrocytic activity
(Yang et al., 2015). Transgenic DREADD (Designer Receptor
Exclusively Activated by Designer Drug) mice were crossed
with GFAP::Cre mice to produce GFAP::Cre;hM3Dq and
GFAP::Cre;hM4Di offspring. In spinal cords or spinal slices from
GFAP::Cre;hM3Dq and GFAP::Cre;hM4Di neonates, perfusion
with the specific DREADD agonist Clozapine-N-Oxide (CNO)
should excite (hM3Dq) or inhibit (hM4Di) astrocytes.
To first validate the ability of the DREADD receptors to excite
or inhibit astrocytes in hM3Dq and hM4Di mice respectively,
Ca2+ imaging was performed in triple transgenic mice expressing
GFAP::Cre;GCAMP6s;hM3Dq or GFAP::Cre;GCAMP6s;hM4Di
(Figures 3A–C). Perfusion of CNO (1 µM) to spinal cord
slices evoked robust Ca2+ responses in astrocytes expressing
hM3Dq (Figure 3A) but had no clear effect on non-transgenic
control astrocytes (Figure 3B) or astrocytes expressing hM4Di
(Figure 3C). We then confirmed that activation of the
inhibitory hM4Di receptor with CNO (2 µM) diminished the
responses of astrocytes to applications of glutamate, as compared
with hM4Di-expressing astrocytes that were not incubated in
CNO (Figures 3D–H; n = 4 slices; t = 4.0; p < 0.007).
Similarly, we demonstrated that 26 astrocytes from the same
GFAP::Cre;GCAMP6s;hM4Di spinal cord slice showed little
response to glutamate in the presence of CNO (2 µM), but
showed more typical responses to glutamate after the CNO was
washed off (Supplementary Figure S2). These results suggest
that pharmacogenetics can be used to either excite or inhibit
spinal cord astrocytes using Cre-driven hM3Dq and hM4Di
receptor activation respectively.
We next addressed whether activation or inhibition of
astrocytes using DREADDs could modulate fictive locomotion
recorded from isolated spinal cord preparations. Fictive
locomotion was recorded from the upper lumbar roots
(L1–3) of isolated spinal cords from control (n = 9),
GFAP::Cre;hM3Dq (hM3Dq; n = 10) and GFAP::Cre;hM4Di
(hM4Di; n = 11) mice (Figures 4A–C). There was no significant
difference in the baseline amplitude, duration or frequency of
locomotor bursts between control, hM3Dq and hM4Di cords
(SupplementaryFigures S3A,B), confirming that the expression
of the DREADD receptors in astrocytes alone had no significant
effect on spinal motor circuits. The application of CNO (2 µM)
had no effect on the frequency of fictive locomotion in control
spinal cords (Figure 4D; F(2,18) = 1.5; p = 0.256). However,
CNO caused a significant reduction in burst frequency in
hM3Dq cords (Figure 4E; F(2,18) = 4.0; p < 0.05). In contrast,
CNO elicited an increase in burst frequency in hM4Di cords
(Figure 4F; F(2,20) = 9.5; p < 0.01). CNO had no significant
effect on burst duration (Supplementary Figures S3C–E) or
amplitude (Supplementary Figures S3F–H) in control, hM3Dq
or hM4Di cords.
It has previously been suggested that pharmacologically
stimulated astrocytes modulate fictive locomotion through
adenosine signaling (Acton and Miles, 2015; Witts et al., 2015;
Acton et al., 2018), which can be inhibited by the A1 adenosine
receptor antagonist, DPCPX at 50 µM (Witts et al., 2012;
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FIGURE 2 | Astrocytic metabotropic glutamate receptor 5 (mGluR5) receptors mediate neuronal-to-astrocyte signaling in the mammalian spinal cord. (A) Example
traces from Ca2+ imaging of astrocytes during local applications of vehicle control artificial cerebrospinal fluid (aCSF), N-methyl-D-aspartate (NMDA) and
(RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) in the presence of TTX (1 µM). Traces from 10 cells from within the same experiment are shown for each agonist
overlayed. Traces are displayed in a red-hue if responsive to the drug, and blue if non-responsive. (B) Bar chart displaying the density of astrocytes that responded to
a given pharmacological stimulus. The agonist concentrations and the number of slices (n number) for each agent are listed below the graph. (C) Visualization of
mGluR5 receptor expression in glutamine synthetase-labeled astrocytic cell bodies (i), primary leaflet/processes (ii) and finer processes (iii). (D) 3D visualization of
mGluR5 localization on astrocytes with orthogonal views of XY, XZ and YZ. Arrows denote cases of colocalization between mGluR5 and glutamine synthetase
observed in 3D. (E) Application of NMDA in spinal cord slices from GFAP::Cre;GCAMP6s mice enables the visualization of astrocyte activity in response to neuronal
activation. NMDA does not activate astrocytes directly (see Figure 3). (F) Application of NMDA in the presence of mGluR5 antagonist
Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP) shows attenuated responses from astrocytes. (G) Bar chart showing that the degree of astrocytic activation
15 min after NMDA application was significantly reduced when slices were incubated in the mGluR5 antagonist, MPEP. (H) Bar chart showing the number of
astrocytes that responded to neuronal activity induced by NMDA was reduced in the presence of MPEP. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; ns, not significant.
Acton and Miles, 2015). We, therefore, utilized DPCPX to
assess whether modulation of fictive locomotion following
pharmacogenetic manipulation of astrocytic activity involves
adenosine signaling. We found that there was no change in
locomotor frequency when astrocytes in hM3Dq (n = 10) and
hM4Di (n = 11) cords were stimulated with CNO in the presence
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FIGURE 3 | Pharmacogenetic techniques can manipulate astrocytic Ca2+ activity in the mammalian spinal cord. (A) Ca2+ imaging of GFAP::cre;GCAMP6s
astrocytes in response to Clozapine-N-Oxide (CNO). Example (top), and averaged (bottom) traces of Ca2+ imaging from astrocytes during applications of CNO
(19 cells for averaged trace). (B) Ca2+ imaging of GFAP::cre;GCAMP6s;hM3Dq astrocytes in response to CNO. Example (top), and averaged (bottom) traces of Ca2+
imaging from astrocytes during applications of CNO (25 cells for averaged trace). (C) Ca2+ imaging of GFAP::cre;GCAMP6s;hM4Di astrocytes in response to CNO.
Example (top), and averaged (bottom) traces of Ca2+ imaging from astrocytes during applications of CNO (30 cells for averaged trace). (D) Ca2+ responses in
GFAP::cre;GCAMP6s;hM4Di astrocytes in response to glutamate, perfused in TTX to prevent neuronal-mediated responses. (E) Example traces of Ca2+ responses
in GFAP::cre;GCAMP6s;hM4Di astrocytes in response to glutamate. (F) Ca2+ responses in GFAP::cre;GCAMP6s;hM4Di astrocytes in response to glutamate,
perfused in both TTX and CNO to inhibit astrocyte activity. (G) Example traces of Ca2+ responses in GFAP::cre;GCAMP6s;hM4Di astrocytes showing no response to
glutamate due to pharmacogenetic inhibition with CNO. (H) Bar chart displaying the number of astrocytes responding to glutamate in GFAP::cre;GCAMP6s;hM4Di
spinal cord slices under control conditions and when perfused with CNO to inhibit astrocytes. ∗∗p < 0.01.
of DPCPX (50 µM; hM3Dq: F(1.28,11.5) = 0.23; p = 0.702; hM4Di:
F(2,20) = 1.0; p = 0.414; Figures 4G,H).
Finally, we interrogated the neuron-astrocyte signaling
mechanism responsible for driving astrocyte-derived purinergic
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FIGURE 4 | Astrocytes exert purinergic modulation of locomotion in response to mGluR5 dependent activation. (A) Example raw (top) and rectified/integrated
(bottom) traces of pharmacologically induced fictive locomotor bursts recorded from in vitro spinal cord preparations from control non-transgenic neonatal mice. The
burst frequency, duration and amplitude were analyzed in control conditions, in the presence of CNO and following the washout of CNO. (B) Pharmacologically
induced fictive locomotor bursts recorded from a GFAP::cre;hM3Dq (excitatory DREADD) neonatal mouse spinal cord in vitro during control conditions, in the
presence of CNO and following the washout of CNO. (C) Pharmacologically induced fictive locomotor bursts recorded from a GFAP::cre;hM4Di (inhibitory DREADD)
neonatal mouse spinal cord in vitro during control conditions, in the presence of CNO and following the washout of CNO. (D) Bar chart displaying the frequency of
fictive locomotor bursts in control, non-transgenic mouse spinal cords in response to CNO. (E) Bar chart displaying the frequency of fictive locomotor bursts in
excitatory DREADD mouse spinal cords in response to CNO. (F) Bar chart displaying the frequency of fictive locomotor bursts in inhibitory
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 February 2020 | Volume 14 | Article 30
Broadhead and Miles Neuron-Astrocyte Signaling Modulates Motor Circuits
FIGURE 4 | Continued
DREADD mouse spinal cords in response to CNO. (G) Bar chart displaying
the frequency of fictive locomotor bursts in excitatory DREADD mouse spinal
cords in response to CNO when perfused with
8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) throughout to block the
adenosine A1 receptor. (H) Bar chart displaying the frequency of fictive
locomotor bursts in inhibitory DREADD mouse spinal cords in response to
CNO when perfused with DPCPX throughout to block the adenosine
A1 receptor. (I) Example traces of fictive locomotion recorded from in vitro
spinal cord preparations from control non-transgenic neonatal mouse spinal
cords, showing the effects of a 20 min application of the A1 receptor
antagonist, DPCPX. (J) Bar chart showing that the frequency of fictive
locomotion is significantly increased with the application of DPCPX. (K)
Example traces of fictive locomotion recorded from in vitro spinal cord
preparations, showing blockade of the effects of the application of DPCPX
when in the presence of MPEP. (L) Bar chart showing that DPCPX has no
effect on the frequency of fictive locomotion when spinal cords are also
incubated in MPEP. ∗p < 0.05; ns, not significant.
modulation of the locomotor CPG. Having shown that glutamate
and the mGluR5 agonist, CHPG, evoked robust Ca2+ responses
in a high proportion of spinal astrocytes, we hypothesized
that glutamatergic signaling, acting via mGluR5, represents
the physiological activator of astrocyte-derived adenosine-
dependent modulation. We, therefore, assessed whether blocking
the mGluR5 receptor could reduce astrocytic adenosine-
mediated modulation of the locomotor CPG. In isolated
spinal cords from control non-transgenic mice (P1–5; n = 8),
fictive locomotion was induced pharmacologically, and DPCPX
(50 µM) was applied for 20 min to block astrocyte-derived
adenosine (Figure 4I). Consistent with the pharmacogenetic
inhibition of astrocytes, A1-receptor inhibition with DPCPX
significantly increased the frequency of fictive locomotion
(Figure 4J; F(2,14) = 5.9; p < 0.05). DPCPX showed no effect
on burst duration (data not shown, F(2,14) = 1.9; p = 0.19)
or amplitude (data not shown, F(2,14) = 0.9; p = 0.44). In
separate experiments, fictive locomotion was initiated in spinal
cords (n = 8) which were then subsequently perfused with
the mGluR5 antagonist MPEP (10 µM) for 20 min, followed
by MPEP and DPCPX together, after-which both MPEP and
DPCPX were washed out (Figure 4K). No significant differences
in the frequency of locomotion were observed between Control,
MPEP, MPEP+DPCPX and Washout conditions (Figure 4L;
F(1.53,10.73) = 0.35; p = 0.657). From this final experiment,
we conclude that inhibiting mGluR5-mediated activation of
astrocytes reduces the astrocytic release of purines and thus
the degree of adenosine-dependent neuromodulation of the
locomotor CPG.
DISCUSSION
In this study, we have used pharmacogenetic manipulation
of astrocytes to show that astrocytes actively modulate spinal
cord motor circuitry. Furthermore, live imaging of astrocytic
activity in the isolated spinal cord suggests they respond to
the activity of ventral interneurons that may form part of the
spinal cord locomotor CPG. The evidence we present here
suggests a modulatory feedback loop between astrocytes and
neurons that depends on bi-directional communication between
these two cell groups. In our proposed model, locomotor CPG
activity, and associated increases in glutamatergic signaling
between CPG neurons, activates astrocytes through the mGluR5
receptor. Astrocytic activation evokes the release of ATP which
is metabolized extracellularly to adenosine. Adenosine acts at
A1 receptors to inhibit interneurons within the CPG, which in
turn affects the frequency of motor output.
Previous research has focussed on the astrocyte-to-neuron
communication mechanisms that may impact motor circuits
(Witts et al., 2012, 2015; Acton and Miles, 2015, 2017;
Acevedo et al., 2016; Acton et al., 2018; Rivera-Oliver
et al., 2018). In this study, we have identified previously
unexplored neuron-to-astrocyte signaling mechanisms which
may drive astrocyte-dependent modulation of the spinal cord
locomotor CPG. We reveal that astrocytes are active during
fictive locomotion in the isolated hemisected spinal cord,
supporting observations from in vivo imaging of glia in the
awake and moving adult mouse (Sekiguchi et al., 2016).
The results from our experiments utilizing pharmacologically-
induced fictive locomotion in the hemisected spinal cord do
not definitively distinguish whether astrocytic activity gradually
increases following the pharmacological stimulation of the
neurons or whether astrocytic activity is specifically enhanced
when rhythmic neural activity emerges. However, we also
observed astrocytic responses to direct stimulation of ventral
horn interneurons, and given that astrocyte manipulation using
DREADDs only affected the frequency of locomotor output,
these results offer compelling evidence that astrocytic activity is
functionally linked to the locomotor CPG interneurons.
We provide compelling evidence that mGluR5 is necessary
for the neuron-astrocyte signaling pathway that drives astrocytic
modulation within the spinal cord. There is considerable
literature on the expression of mGluRs by astrocytes and the
role of mGluR5 at the tripartite synapse as a mechanism
for astrocytes to detect synaptic activity (Ota et al., 2013;
Panatier and Robitaille, 2016). Our data supports this theory,
as spinal astrocytes express mGluR5 and responded robustly
to the mGluR5 agonist, CHPG. Blocking the mGluR5 receptor
reduced astrocytic activity and blocked the modulatory effects
of astrocyte-derived adenosine on fictive locomotion, suggesting
that mGluR5 signaling could be the ‘‘driving force’’ behind
astrocytic modulation of motor output.
We have previously shown that astrocyte activation in
P1–4 neonatal mouse spinal cords using a PAR1 agonist reduces
the frequency of fictive locomotion (Acton and Miles, 2015),
which matches our current findings here that DREADD-based
activation of astrocytes in P6–8 spinal cords leads to reduced
locomotor frequency. This suggests that the neuronal-astrocytic
interactions underlying this modulatory feedback mechanism are
preserved throughout early developmental stages. Whether this
bi-directional signaling mechanism exists in adult mice remains
to be explored. On the one hand, there is evidence that spinal
astrocytes respond to walking-like behavior in the awake adult
mouse (Sekiguchi et al., 2016), in a manner that is comparable
to the effects we observe in our study. On the other hand,
mGluR5 expression in astrocytes may not exist past adolescence
(Sun et al., 2013), suggesting there could be developmentally
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regulated alterations in this bi-directional signaling pathway
controlling the locomotor CPG.
Interestingly, mGluR5 antagonism did not completely abolish
the Ca2+ transients we observed in astrocytes in response to
neuronal activity. This suggests that multiple, parallel pathways
of neuron-to-astrocyte signaling may occur in the spinal cord.
Several other neurotransmitters and neuromodulators evoked
Ca2+ transients in small numbers of spinal astrocytes. Although
these responses were not significantly greater than those
observed after applications of aCSF, we cannot exclude the
possibility that non-mGluR5 mediated neural-glial transmission
may occur. The inhibitory neurotransmitters GABA and Glycine
may be the most likely candidates for low-level neuron-to-
astrocyte signaling, given the increasing body of literature on
inhibitory tripartite synapse interactions (Garrett and Weiner,
2009; Matos et al., 2018; Allen, 2019; Nagai et al., 2019),
the expression of inhibitory neurotransmitter receptors by
spinal glial cells (Kirchhoff et al., 1996), and evidence that
spinal astrocytes may modulate inhibitory synaptic release
probability (Witts et al., 2015). While there is some evidence
that astrocytes may express 5-HT and DA receptors, activation
of these receptors may not lead to Ca2+ transients, and may
instead hyperpolarize astrocytes (Hösli et al., 1987; Miyazaki
et al., 2013). Although DA evoked Ca2+ responses in a
small number of astrocytes, we believe that DA is unlikely
to be a key activator of spinal astrocytes. The mammalian
spinal cord lacks dopaminergic neurons; all dopaminergic
input to the spinal cord is derived from descending systems.
Thus, DA could not mediate the responses we observed in
astrocytes following the direct stimulation of interneurons
within isolated spinal cord tissue. Furthermore, astrocytes
only showed elevated activity in hemisected spinal cord
preparations once clear locomotor activity was established,
with no significant response to the application of DA along
with 5-HT and NMDA in the presence of TTX. These
findings, therefore, indicate that astrocytes are responsive to
intrinsic spinal neurotransmitters released during physiological
network activity.
In addition to classic transmitter-based signaling, changes
in the extracellular environment induced by neuronal activity
may also stimulate astrocytic activity. For example, rises in
extracellular K+ concentration, which occurs during neuronal
activity including that of the locomotor CPG (Brocard et al.,
2013), represents an alternative mechanism by which astrocytes
may be activated (Scemes and Spray, 2012; Bellot-Saez et al.,
2017). Given the number of different neurotransmitter receptors
that are reported to be expressed by astrocytes throughout the
nervous system (Verkhratsky and Butt, 2013) and the ability
of spinal astrocytes to respond to multiple neuronally-derived
signals, it is possible that astrocytes act as global integrators
of neuronal activity and contribute to a wide range of spinal
neuromodulatory systems.
There is converging evidence that stimulating astrocytes
pharmacologically, or ablating astrocytes with gliotoxins, reveals
purinergic-dependent, glial-derived modulation of the spinal
cord locomotor CPG (Dale and Gilday, 1996; Dale, 1998; Brown
and Dale, 2000; Witts et al., 2012, 2015; Acton and Miles,
2015; Acevedo et al., 2016; Acton and Miles, 2017; Acton
et al., 2018; Rivera-Oliver et al., 2018). Although astrocytes
in other CNS regions demonstrate the ability to utilize other
transmitters, such as glutamate or GABA (Malarkey and Parpura,
2008; Christensen et al., 2018); there is a paucity of evidence
to suggest that other gliotransmitters are involved in the
astrocytic control of the locomotor CPG. In previous studies,
antagonists of purinergic signaling were sufficient to block all the
astrocytic effects on the locomotor network (Acton and Miles,
2015; Witts et al., 2015; Acton and Miles, 2017; Acton et al.,
2018). In this study, we have employed the pharmacogenetic
DREADD approach to specifically target astrocytes and allow
us to both excite and inhibit astrocytes. The hM3Dq-based
activation of astrocytes elicits a strong response comparable
with the use of the PAR1 agonist, TFLLR, which has been
used to excite astrocytes in previous similar studies (Acton
and Miles, 2015; Acton et al., 2018). While these high levels
of stimulation may invoke non-physiological responses from
cells, it is important to note that the hM4Di-based inhibition
of astrocytes results in a complementary, opposing effect
on fictive locomotion as compared to stimulating astrocytes.
Furthermore, the effects of stimulating and inhibiting astrocytes
were both nullified by blocking A1 adenosine receptors. Our
data, therefore, support previously proposed mechanisms of
glial-mediated modulation of the spinal locomotor CPG. The
theory stands that astrocytes release ATP, which is subsequently
converted to adenosine, which then acts at heteromeric dimers
comprised of A1 adenosine and D1 dopaminergic receptors
on CPG interneurons to reduce neuronal activity (Witts
et al., 2015; Acton and Miles, 2017; Acton et al., 2018;
Rivera-Oliver et al., 2018).
There remains debate as to whether gliotransmission occurs
under physiological conditions, or whether reported incidences
of glia-to-neuron signaling are merely artifacts of in vitro studies
or the stimulation method employed (Fiacco and McCarthy,
2018; Savtchouk and Volterra, 2018). As demonstrated by our
study, the locomotor circuitry of the spinal cord represents
a useful model in which to interrogate these questions. The
spinal cord can be isolated for experimentation while still
conserving the essential sensory inputs and motor outputs for
reflex responses and locomotor activity. The outputs generated
by spinal circuits are measurable and directly correlative to the
in vivo behaviors they serve. Thus, spinal circuits may provide a
practical solution to the gliotransmission debate by avoiding the
caveats of other approaches such as in vitro cell culture studies.
Our results strongly imply a physiological role for the
astrocytic release of purines in modulating a basic, neuronally-
mediated behavior. What remains to be investigated is the
precise gliotransmitter release mechanism in spinal astrocytes;
i.e., whether transmission utilizes vesicular release machinery
or occurs via hemichannel pores formed by connexins. This
could be addressed by using mutant mice with perturbed
Vesicle-Associated Membrane Proteins (VAMPs) or mutated
Connexin-43 which forms hemichannel pores. Recent findings
suggest reactive astrocytes in ALS display enhanced expression
of Connexin 43, contributing to motor neuron toxicity (Almad
et al., 2016). Therefore, understanding the precise signaling
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machinery between both astrocytes and neurons may reveal
therapeutic targets for treating neurodegenerative diseases, such
as ALS.
The locomotor CPG is just one of several rhythmic neural
circuits of the CNS in which gliotransmission has been
interrogated. Astrocytes have been shown to be active in the
respiratory control networks of the brainstem (Guyenet et al.,
2009; Gourine et al., 2010; Okada et al., 2012; Sheikhbahaei
et al., 2018). Chemosensitive astrocytes in the retrotrapezoid
nucleus respond to circulating CO2 and consequently release
ATP to initiate respiration (Gourine et al., 2010; Huxtable
et al., 2010; Sheikhbahaei et al., 2018). Meanwhile, the ATP
metabolite, adenosine, has been shown to exhibit an inhibitory
effect on the respiratory CPG (Huxtable et al., 2010). Studies
into mastication have revealed an entirely different astrocytic
modulatory mechanism. In the rat trigeminal sensorimotor
circuit, astrocytes release the Ca2+ binding protein S100β,
which sequesters extracellular Ca2+ and reduces NMDA-induced
bursting of rhythmogenic neurons that lead to chewing behavior
(Morquette et al., 2015). It is conceivable that this mechanism
is also present in other networks such as those controlling
respiration or locomotion.
Feeding behavior is also regarded as rhythmic, though not
strictly under the control of a CPG but rather orchestrated
by an ‘‘entrained oscillator’’ in the medial basal hypothalamus
(Mieda et al., 2006). Here in the hypothalamus, astrocytes also
act as a source of adenosine to modulate feeding behavior (Yang
et al., 2015). In this instance, pharmacogenetic manipulation of
astrocytes demonstrated their ability to bi-directionally modulate
food intake in mice, helping to maintain feeding within a
constrained range to prevent energy deficit or surfeit.
Glial cells have also been implicated in the control of rhythmic
CPGs in the periphery, for example, within networks of the
enteric nervous system that regulate gut motility patterns (Smith
and Koh, 2017). Here it has been shown that enteric glia (likened
to CNS astrocytes) are responsive to neural-mediated motor
events that aid in colonic transport of fecal matter (MacEachern
et al., 2011; Broadhead et al., 2012; McClain et al., 2014, 2015).
Genetic manipulations that perturb astrocytic gliotransmitter
release mechanisms significantly affected colonic fecal transit in
mice (Grubisˇi´c and Parpura, 2017). The nature of the enteric glial
transmitter involved remains unknown, but both ATP and NO
are implicated (Gulbransen and Sharkey, 2012).
There are clearly diverse roles for astrocytes and other glial
cells throughout the nervous system. A growing body of evidence
indicates that astrocytes play active roles within many neural
circuits, as they are able to respond to neuronal signaling
and release chemical messengers via gliotransmission. While it
remains to be determined whether there is any conserved logic
to the role of astrocytes within neural circuits, our study on the
locomotor CPG indicates a purinergic-dependent modulation
of rhythmogenic neural network activity, which is driven by
glutamate derived from the neural network itself. Based on
previous literature (Yang et al., 2015; Cinelli et al., 2017;
Sheikhbahaei et al., 2018), it is conceivable that astrocyte-derived
purinergic modulation is a key mechanism within rhythmic
circuits, which helps to constrain network output in order to
control rhythmic behaviors. Further advances in our knowledge
of the roles of glial cells within neural circuits will pave the
way for a greater understanding of how the nervous system
coordinates behavior.
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FIGURE S1 | Astrocyte cell density using a fluorescence reporter line. (A) Spinal
cord slices were prepared from GFAP::Cre;TdTomato neonatal mice and images
of the ventral horn were captured. Red fluorescent cells were counted to estimate
the total density of astrocytes (n = 12 spinal cord slices from two mice, P8–9). (B)
Box and whisker plot showing the average number of TdTomato +ve astrocytes in
neonatal spinal cord slices per mm2.
FIGURE S2 | Inhibition of spinal astrocytes using hM4Di DREADD receptor
activation. (A) Spinal cord slice prepared from a neonatal
P8 GFAP::Cre;GCAMP6s;hM4Di mouse. Astrocytes from the same slice were
visualized using Ca2+ imaging to investigate their responses to Glutamate with
and without the presence of CNO to inhibit them (n = 26). (B) Astrocytes were first
visualized in the presence of TTX and CNO, to block neurons and
hM4Di-expressing astrocytes respectively. Three example traces are shown of
three astrocytes, and an averaged trace of the ∆F/F0 with standard deviation
from a total of 26 astrocytes. (C) After the first recording, CNO was washed off for
15 min leaving only TTX to inhibit the neurons. The three traces depict the
∆F/F0 from the same three cells as in panels (A,B). A greater number of cells
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responded to glutamate, typically showing a more sustained ∆F/F0 elevation,
when CNO was absent.
FIGURE S3 | Additional fictive locomotor bursting parameters for control
(non-transgenic), GFAP::cre;hM3Dq and GFAP::cre;hM4Di neonatal spinal cords.
(A) Bar chart showing the duration of fictive locomotor bursts in each of the three
genotypes of mice used. (B) Bar chart showing the frequency of fictive locomotor
bursts in each of the three genotypes of mice used. (C) Bar charts displaying the
burst duration under control, CNO and wash conditions for control
(non-transgenic) spinal cords. (D) Bar charts displaying the burst duration under
control, CNO and wash conditions for GFAP::Cre;hM3Dq spinal cords. (E) Bar
charts displaying the burst duration under control, CNO and wash conditions for
GFAP::Cre;hM4Di spinal cords. (F) Bar charts displaying the burst amplitude
under control, CNO and wash conditions for control (non-transgenic) spinal cords.
(G) Bar charts displaying the burst amplitude under control, CNO and wash
conditions for GFAP::Cre;hM3Dq spinal cords. (H) Bar charts displaying the burst
amplitude under control, CNO and wash conditions for GFAP::Cre;hM4Di spinal
cords. ns, not significant.
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